Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP627888.RAW7Cfsu1fboQh2JL95OBZTillNYpTYYS5ysN0p0rFEoA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP627888.RAW7Cfsu1fboQh2JL95OBZTillNYpTYYS5ysN0p0rFEoA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP627888.RAW7Cfsu1fboQh2JL95OBZTillNYpTYYS5ysN0p0rFEoA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP627888.RAW7Cfsu1fboQh2JL95OBZTillNYpTYYS5ysN0p0rFEoA130_provenance.
- NP627888.RAW7Cfsu1fboQh2JL95OBZTillNYpTYYS5ysN0p0rFEoA130_assertion description "[A clinical trial with the sPLA(2) inhibitor varespladib methyl was recently terminated, while clinical trials with the Lp-PLA(2) inhibitor darapladib are being conducted in coronary heart disease patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627888.RAW7Cfsu1fboQh2JL95OBZTillNYpTYYS5ysN0p0rFEoA130_provenance.
- NP627888.RAW7Cfsu1fboQh2JL95OBZTillNYpTYYS5ysN0p0rFEoA130_assertion evidence source_evidence_literature NP627888.RAW7Cfsu1fboQh2JL95OBZTillNYpTYYS5ysN0p0rFEoA130_provenance.
- NP627888.RAW7Cfsu1fboQh2JL95OBZTillNYpTYYS5ysN0p0rFEoA130_assertion SIO_000772 22802388 NP627888.RAW7Cfsu1fboQh2JL95OBZTillNYpTYYS5ysN0p0rFEoA130_provenance.
- NP627888.RAW7Cfsu1fboQh2JL95OBZTillNYpTYYS5ysN0p0rFEoA130_assertion wasDerivedFrom befree-20150227 NP627888.RAW7Cfsu1fboQh2JL95OBZTillNYpTYYS5ysN0p0rFEoA130_provenance.
- NP627888.RAW7Cfsu1fboQh2JL95OBZTillNYpTYYS5ysN0p0rFEoA130_assertion wasGeneratedBy ECO_0000203 NP627888.RAW7Cfsu1fboQh2JL95OBZTillNYpTYYS5ysN0p0rFEoA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP627888.RAW7Cfsu1fboQh2JL95OBZTillNYpTYYS5ysN0p0rFEoA130_provenance.